On October 26, 2023, the Yunnan Provincial Drug Administration issued the “Implementation Rules for the Grading Supervision of Medical Device Production Risk in Yunnan Province (Trial)(hereinafter referred to as the Rules). In response to the development characteristics of the medical device industry in the province, and in combination with the relevant requirements of the NMPA and the Provincial Market Supervision Bureau, the Rules were formulated to further strengthen the effective identification, scientific prevention and control, and precise governance of risks. more…
On November 3, 2023, the NIFDC issued the Summary of the Third Medical Device Product Classification and Definition Results in 2023 (hereinafter referred to as the “Summary of results”), and announced a total of 261 medical device product classification and definition results from May 2023 to September 2023 more…
According to the data of a research report, the total number of registered cases of coronary intervention in Chinese Mainland in 2020 exceeded 1 million (excluding cases in military hospitals), an increase of 20.18% over 2020. more…
China has created multiple global “firsts” in the field of robotic remote surgery. China has completed the world’s first remote robotic surgery, the world’s farthest robotic surgery, and the world’s first remote micrometer level ophthalmic surgery. more…
On 18 October 2023, NMPA released NMPA Integrated Division Publicly Solicits Opinions on <Management Requirements for Temporary Import and Use of Clinically Urgent Medical Devices in Healthcare Institutions (Draft for Public Comment)>, which is now open for public comment, and feedback can be provided by email before 15 November. more…
